SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

B. Riley FBR Maintains Buy on Novavax, Raises Price Target to $43

B. Riley FBR maintains Novavax (NASDAQ:NVAX) with a Buy and raises the price target from $29 to $43.

Benzinga · 05/12/2020 11:53

B. Riley FBR maintains Novavax (NASDAQ:NVAX) with a Buy and raises the price target from $29 to $43.